Home›People›Theodore Alexandrov
Theodore Alexandrov

Theodore Alexandrov

CEO & Co-founder at DeepCyte.

Executive
Updated Nov 16, 2026·Latest SEC filing Jan 29, 2026·Suggest an edit

About Theodore Alexandrov

Theodore Alexandrov is CEO & Co-founder at DeepCyte.

Experience

This experience comes from Theodore Alexandrov's profile and from SEC filings. For roles taken from filings, the years are when the filings name Theodore Alexandrov in the role, so the role may have started earlier or lasted longer.

DeepCyte Inc. Current
CEO & Co-founder
CEO & Founder (2025 – Present)
2025 – Present · Wilmington, DE
AI tools help drug developers predict and understand toxicity in human cells.
METASPACE Imaging MS Platform Current
Principal Investigator
2014 – Present
UC San Diego Current
Assistant Professor
2010 – Present
BioInnovation Institute
BioStudio Principal Investigator
2022 – 2024
Heidelberg University
Faculty at the Molecular Medicine Partnership Unit
2020 – 2024
EMBL
Team Leader, Founder & Head of Metabolomics Core Facility
2014 – 2024
SCiLS GmbH
Scientific Director @ Founder
2012 – 2017
University of Bremen
Head of Life Science Group, head of MALDI Imaging Lab
2010 – 2014

Sources

  1. SECDeepCyte Inc. Form D, filed Jan 29, 2026